We do the sorting. You do the medicine.

Pharmacology

Sheet 03Anaesthesia

Pharmacology

Dosing for the patient in front of you, relaxants and reversal, MAC and the volatiles, drug classes and the interactions that bite.

Cards
21
Minutes
about16
Scenarios
21

Start at card 1Review the rules

Core rulesRead these first3 cards · about 2 min

  1. 01Dosing by weight, age and organ function
  2. 02Depth decides the reversal
  3. 03Minimum alveolar concentration (MAC): what moves it

Dosing by weight, age and organ function

01 / 21

Scale every dose to this patient: weight scalar, age, kidneys and brain each change it.

Dose by patient group

PatientDose
Obesity, open its explanationSuccinylcholine on total body weight; rocuronium on lean
Older adult, open its explanationRemifentanil: half bolus, infusion about one‑third young‑adult rate
Older adult, open its explanationCisatracurium: usual dose, no adjustment; onset slightly slower
Cerebral palsy, open its explanationLess volatile; slow relaxant recovery; on anticonvulsants, resistance: monitor

Duration and sensitivity by patient group

PatientEffect
Older adult, open its explanationPropofol, midazolam: brain more sensitive; etomidate disputed
Older adult, open its explanationSlower clearance, longer drug effect; only body fat rises
End‑stage renal disease, open its explanationRocuronium modestly prolonged: reduced renal excretion
Neonate or infant, open its explanationRemifentanil cleared fastest, faster than older children

Report a problem with card 1: Dosing by weight, age and organ function

Depth decides the reversal

02 / 21

Count twitches first: deep block sugammadex, four twitches neostigmine; extubate only at a ratio of 0.9.

Reversal by depth of block

Relaxant and depthReversal
Cisatracurium, fewer than four twitches, open its explanationDo not reverse yet; ventilate until four twitches
Cisatracurium, four twitches, open its explanationNeostigmine 40–50 mcg/kg plus antimuscarinic; confirm quantitatively
Rocuronium, train‑of‑four zero, post‑tetanic 1–2, open its explanationDeep block: sugammadex 4 mg/kg
Rocuronium given, failed intubation, decision to wake, open its explanationSugammadex 16 mg/kg; failed oxygenation needs front‑of‑neck access
Rocuronium, train‑of‑four ratio under 0.9 after neostigmine, open its explanationStay intubated; give sugammadex
Rocuronium, ratio under 0.9, neostigmine top‑up, open its explanationAt most 50 mcg/kg total (ASA); stay intubated

Sugammadex binding strength

RelaxantSugammadex binding
Rocuronium, open its explanationBinds most tightly; vecuronium less, pancuronium negligibly

Report a problem with card 2: Depth decides the reversal

Minimum alveolar concentration (MAC): what moves it

03 / 21

MAC falls with age, pregnancy, cold, lithium and depressants; rises with heat, sodium and chronic alcohol.

Raises MAC

Raises MACHow much or why
Hyperthermia, open its explanationRaises MAC; not ranked against chronic alcohol
Chronic alcohol, open its explanationRaises MAC; size unknown, not ranked against fever
Hypernatraemia, open its explanationRaises MAC
Infancy, open its explanationRaises MAC; infants need more volatile agent

Lowers MAC

Lowers MACHow much or why
Pregnancy, open its explanation28% in the first trimester (Miller); 25–40% (Faust)
Lithium, α2‑agonists, barbiturates, hypothermia, open its explanationLower MAC
Advancing age, open its explanationAbout 6% per decade
Acute levodopa, open its explanationLowers MAC in animals only; no human data

No reported effect on MAC

DrugWhat the books show
Cyclosporine, open its explanationAbsent from every MAC table in the books

Report a problem with card 3: Minimum alveolar concentration (MAC): what moves it

Part 1 · DecisionsWhat to do5 cards · about 4 min

  1. 04The medicine list
  2. 05Relaxant choice: give, avoid, prevent
  3. 06Antiemetic choice
  4. 07Drug for the job
  5. 08Doses and numbers

The medicine list

04 / 21

Check the medicine list first: it bars a drug, changes a level or forbids an antidote.

Antidepressants and opioids

Patient's medicineWhat changes
Monoamine oxidase (MAO) inhibitor, including selegiline, open its explanationAvoid pethidine, tramadol and methadone
MAO inhibitor needing opioid analgesia, open its explanationGive morphine; fentanyl‑type opioids with caution
MAO inhibitor with hypotension, open its explanationSmall titrated phenylephrine; never ephedrine
Tricyclic, selective serotonin reuptake inhibitor (SSRI) or existing seizure risk, open its explanationUse tramadol only with caution
Tramadol plus a tricyclic, open its explanationSeizures and serotonin syndrome

Other medicines and herbal remedies

Patient's medicineWhat changes
Cyclosporine with ranitidine or cimetidine, open its explanationPotentiated renal dysfunction (label list)
Cyclosporine with metoclopramide, open its explanationCyclosporine level rises
Cyclosporine or tacrolimus with phenytoin, open its explanationLower level and effect
Hydroxychloroquine, open its explanationQT prolongation; avoid other QT‑lengthening drugs
Feverfew, open its explanationRebound headache on abrupt stopping
Valerian, open its explanationSedative, potentiates anaesthetics; mild enough to continue

Methaemoglobinaemia and methylene blue

PatientAction
Dapsone with cyanosis despite high‑flow oxygen, open its explanationMethaemoglobinaemia: co‑oximetry, stop drug, methylene blue 1 to 2 mg/kg
Glucose‑6‑phosphate dehydrogenase (G6PD) deficiency, open its explanationNever methylene blue, even for methaemoglobinaemia

Report a problem with card 4: The medicine list

Relaxant choice: give, avoid, prevent

05 / 21

Succinylcholine is barred by myopathy, burns past 24 hours or cholinesterase defect; pretreat its side effects.

Choosing the relaxant

Clinical settingRelaxant decision
Myotonic dystrophy or other myopathy, open its explanationAvoid succinylcholine; myasthenia gravis is not a contraindication
Burns within the first 24 hours, open its explanationSuccinylcholine safe
Burns past 24 hours, hyperkalaemia peak 7–10 days, open its explanationAvoid succinylcholine
Burns, non‑depolariser needed, open its explanationExpect resistance; give bigger doses
Prolonged recovery after esterase‑cleared drug, open its explanationPlasma cholinesterase deficiency: avoid mivacurium and succinylcholine
Re‑paralysis soon after sugammadex, open its explanationUrgent: succinylcholine; non‑urgent: benzylisoquinolinium; standard rocuronium waits 4 hours
Glaucoma, intact globe, open its explanationSuccinylcholine allowed; rise peaks 2–4 minutes, gone by 6

Preventing succinylcholine side effects

Side effectPrevention
Intraocular pressure rise at succinylcholine and intubation, open its explanationRemifentanil 1 mcg/kg with induction; fentanyl lowers less
Bradycardia: children first dose, adults repeat dose, open its explanationAtropine pretreatment
Succinylcholine myalgia, open its explanationNon‑steroidal anti‑inflammatory drug (NSAID) beforehand; rocuronium pretreatment helps; lower dose does not

Report a problem with card 5: Relaxant choice: give, avoid, prevent

Antiemetic choice

06 / 21

Long QT bars droperidol; Parkinson's bars every dopamine antagonist, so give ondansetron there.

Antiemetic by condition

ConditionAntiemetic
Parkinson's disease, nausea or vomiting, open its explanationOndansetron; never a dopamine antagonist
Parkinson's disease, dopamine‑blocking antiemetics, open its explanationAvoid metoclopramide, droperidol, haloperidol, promethazine, thiethylperazine
Prolonged QT with syncope, open its explanationAvoid droperidol: torsades risk

Antiemetic site of action

Site of actionAntiemetic
Chemoreceptor trigger zone, D2 blockade, open its explanationDroperidol

Report a problem with card 6: Antiemetic choice

Drug for the job

07 / 21

Match the drug to the task, not to habit.

Drug for the task

TaskDrug
Short‑term sedation, ventilated adults in intensive care, open its explanationDexmedetomidine
Treat postoperative shivering, open its explanationPethidine 12.5–25 mg IV; ondansetron, clonidine, ketamine also work
Still the duodenum for endoscopic retrograde cholangiopancreatography (ERCP) cannulation, open its explanationGlucagon; intravenous hyoscyamine is the alternative
Migraine prevention when asthma bars beta‑blockers, open its explanationAntiepileptic: topiramate or valproate; topiramate for women of childbearing age
Soften electroconvulsive therapy (ECT) convulsions to prevent fractures, open its explanationSuccinylcholine; bite block protects teeth and tongue
Rescue inadequate ECT seizure under propofol, open its explanationSwitch induction to etomidate

The drug that ranks first

PropertyDrug
Benzodiazepine with shortest elimination half‑life, open its explanationMidazolam, not lorazepam or alprazolam
Largest fall in cerebral metabolic rate, open its explanationThiopental or propofol, about 60% at burst suppression
Strongest mydriasis and sedation, open its explanationScopolamine, then atropine; not glycopyrrolate
Strongest drying of salivary secretions, open its explanationGlycopyrrolate, over atropine and scopolamine
Least effect on urine output, open its explanationFentanyl; volatile agents reduce it
Strongest anti‑inflammatory steroid for joint injection, open its explanationBetamethasone (potency 25)

Report a problem with card 7: Drug for the job

Doses and numbers

08 / 21

Stay under the ceiling, convert by fixed ratios, dilute by arithmetic, and dose by weight.

Daily ceilings

PatientMaximum in 24 hours
Adult, open its explanationParacetamol 4 g, counting combination tablets
Adult with liver or kidney impairment, open its explanationParacetamol 2 g or less
Child, open its explanationParacetamol under 90 mg/kg

Conversions and dilution

ConversionBedside rule
IV morphine to oral morphine, open its explanationTriple it: 10 mg IV = 30 mg oral morphine
IV morphine to oral oxycodone, open its explanationDouble it: 10 mg IV = 20 mg oxycodone
Adrenaline 1:1000 (1 mg/mL) to 1:10,000, open its explanation1 mL made up to 10 mL = 0.1 mg/mL

Doses by weight

DrugDose
Rocuronium ED95, open its explanation0.3 mg/kg
Rocuronium intubating and rapid sequence doses, open its explanation0.6 mg/kg (2× ED95); 1.2 mg/kg (4× ED95)
Propofol ED50, loss of consciousness after bolus, open its explanation1–1.5 mg/kg
Propofol usual induction dose, open its explanation2–2.5 mg/kg, above the ED50

Report a problem with card 8: Doses and numbers

Part 2 · RecognitionWhat it is4 cards · about 2 min

  1. 09Monitoring the block
  2. 10Depth, EEG and stages
  3. 11Drug syndromes and their antidotes
  4. 12The drug behind the finding

Monitoring the block

09 / 21

Only a measured train-of-four ratio of 0.9 proves recovery; touch and clinical signs miss residual block.

Order of muscle block

Non-depolarising blockMuscles
First muscles blocked by a non‑depolariser, open its explanationLaryngeal adductors, diaphragm; adductor pollicis later

Bedside tests of recovery

TestWhat it shows
Sustained hand grip, open its explanationRecovers after head lift; still not proof without 0.9
Train‑of‑four fade assessed by touch, open its explanationUnreliable above about 0.4; overestimates recovery
Double‑burst fade assessed by touch, open its explanationDetects fade better than train‑of‑four, to about 0.6
No fade felt on either test, open its explanationResidual block not excluded; measure quantitatively to 0.9

Report a problem with card 9: Monitoring the block

Depth, EEG and stages

10 / 21

Read depth from the EEG and the breathing; ketamine fools the bispectral index (BIS).

Processed EEG by agent

AgentEEG effect
Ketamine, open its explanationBIS pushed up; not lighter anaesthesia
Nitrous oxide, open its explanationBIS largely unchanged; not lighter anaesthesia
Isoflurane at about 1.5 MAC, open its explanationEEG burst suppression; flat trace at 1.5–2 MAC

Guedel stages from breathing

Breathing signStage
Unconscious, irregular breathing, going under or emerging, open its explanationStage 2, excitement
Regular breathing, unconscious, open its explanationStage 3

Report a problem with card 10: Depth, EEG and stages

Drug syndromes and their antidotes

11 / 21

Name the drug effect from its signs, then give its antidote, stop the drug, or observe.

The drug behind the finding

12 / 21

Work back from the finding to the one drug that causes it.

Part 3 · SituationsWhat now4 cards · about 2 min

  1. 13Prolonged apnoea after succinylcholine
  2. 14Blood pressure crisis from a drug
  3. 15What prolongs or shortens the block
  4. 16Apnoea from an opioid interaction

Prolonged apnoea after succinylcholine

13 / 21

Prolonged block after succinylcholine means low or atypical cholinesterase: ventilate and check the dibucaine number.

Dibucaine number and genotype

Dibucaine numberGenotype
Dibucaine number 70–80, open its explanationNormal homozygous typical pseudocholinesterase
Dibucaine number 40–60 (Barash), 50–60 (Mayo), open its explanationHeterozygous atypical pseudocholinesterase
Dibucaine number 20–30, open its explanationAtypical homozygous pseudocholinesterase

Cholinesterase activity by patient factor

Patient factorCholinesterase and succinylcholine effect
Pregnancy, open its explanationCholinesterase falls 20–30%; succinylcholine slightly prolonged
Liver disease, plasmapheresis or glucocorticoids, open its explanationLower plasma cholinesterase: succinylcholine prolonged
Obesity, open its explanationRaised plasma cholinesterase; dose succinylcholine on total weight

Report a problem with card 13: Prolonged apnoea after succinylcholine

Blood pressure crisis from a drug

14 / 21

Hypertension after eye drops, stimulants or stopped clonidine is drug-driven: remove the cause, treat the pressure.

PictureCause and response
Hypertension, reflex bradycardia after phenylephrine eye drops, open its explanationPhentolamine or a direct vasodilator; never a beta‑blocker
Hypertension, tachycardia, ischaemia in a cocaine user, open its explanationAcute cocaine intoxication; lasting risks: cardiomyopathy, arrhythmia, stroke
Hypertension, tachycardia despite generous opioid, amphetamine user, open its explanationAcute intoxication: expect a raised anaesthetic requirement
Hypertensive crisis with tachycardia after antihypertensive stopped, open its explanationClonidine withdrawal (8–36 h); continue clonidine perioperatively

Sources: AHA/ACC 2024 · §7.4

Report a problem with card 14: Blood pressure crisis from a drug

What prolongs or shortens the block

15 / 21

Age, cold, respiratory acidosis, magnesium, volatiles and aminoglycosides prolong block; calcium shortens, total intravenous anaesthesia (TIVA) spares.

What prolongs the block or blunts reversal

FactorEffect
Old age, hypothermia, aminoglycosides, open its explanationProlong non‑depolarising block
Magnesium sulfate for pre‑eclampsia, open its explanationPotentiates depolarising block as well as non‑depolarising block
Magnesium sulfate, then neostigmine reversal, open its explanationRecovery blunted; give smaller relaxant doses, titrate to monitoring
Respiratory acidosis (Miller: also metabolic alkalosis), open its explanationImpairs neostigmine reversal; correct hypercarbia first
Volatile agents, open its explanationRaise residual blockade risk

What shortens the block or lowers residual risk

FactorEffect
Hypercalcaemia (hyperparathyroidism), open its explanationShortens non‑depolarising block; lower sensitivity
Young age, TIVA, open its explanationLower residual blockade risk

Report a problem with card 15: What prolongs or shortens the block

Apnoea from an opioid interaction

16 / 21

Opioid apnoea means more active drug: fast metaboliser, enzyme inhibitor, warmed patch or sensitive neonate.

Part 4 · Conditions and mechanismsWhy it is true4 cards · about 4 min

  1. 17Kinetic principles and routes
  2. 18Context-sensitive half-time
  3. 19Volatile agents and gases
  4. 20Drug, class and receptor

Kinetic principles and routes

17 / 21

Ionisation, binding and enzyme capacity decide where a drug goes; the route decides first pass.

Distribution and metabolism

PrincipleWhat it means
Un‑ionised drug form, open its explanationLipid soluble: crosses placenta; reabsorbed by renal tubule
Fick's law of placental transfer, open its explanationRises with surface area, gradient; falls with thickness
Local anaesthetic duration of action, open its explanationProtein binding (pKa sets onset speed)
Phase II hepatic metabolism, open its explanationConjugation, mostly glucuronidation; oxidation is Phase I
Zero‑order kinetics, open its explanationEnzymes saturated: constant amount cleared per unit time
Offset of single propofol bolus, open its explanationRedistribution, not metabolism

Dose-response terms

Dynamics termWhat it means
Potency on dose‑response curve, open its explanationLower ED50, further left; efficacy is plateau height
Tolerance: two mechanisms, open its explanationReceptor adaptation (acute, within anaesthesia); enzyme induction (chronic exposure)

First pass by route

RouteFirst-pass effect
Oral route, open its explanationMost first‑pass hepatic metabolism
Intravenous versus oral morphine, open its explanationFirst‑pass metabolism: oral bioavailability 20–30%
Proximal versus distal rectum, open its explanationProximal via portal vein; distal avoids first pass
Midazolam bioavailability by route, open its explanationIntramuscular >90%, intranasal 74–76%, rectal 40–65%, oral 31–72%

Report a problem with card 17: Kinetic principles and routes

Context-sensitive half-time

18 / 21

Offset after an infusion grows with its length: fentanyl and dexmedetomidine most, propofol little, remifentanil never.

Offset after an infusion

DrugOffset behaviour
Remifentanil, open its explanationConstant about 3 to 5 min, however long the infusion
Fentanyl, open its explanationRises steeply; about 250 minutes after a 6‑hour infusion
Dexmedetomidine, open its explanation4 min after 10‑min infusion; 250 min after 8 hours
Propofol, open its explanationUnder 40 minutes; barely lengthens with infusion length

Kinetic terms defined

TermWhat it means
Meaning of 'context' within context‑sensitive half‑time, open its explanationInfusion duration
Elimination half‑life, open its explanationTime for plasma level to halve after distribution
Clearance, open its explanationPlasma volume cleared of drug per unit time
Predicting plasma fall after an infusion stops, open its explanationContext‑sensitive half‑time, not elimination half‑life
How fast the effect starts, open its explanationEffect‑site equilibration time

Report a problem with card 18: Context-sensitive half-time

Volatile agents and gases

19 / 21

Solubility sets speed, lipid solubility sets potency; each agent has its own effects.

Solubility and potency

PropertyWhat it predicts
FA/FI shift with ventilation, cardiac output, open its explanationLeast for desflurane, most for soluble agents
Lowest blood:gas solubility, open its explanationDesflurane 0.45, just below nitrous oxide 0.47
Isoflurane blood:gas solubility, open its explanationIntermediate: 1.4, between sevoflurane 0.65 and halothane 2.5
Lipid solubility (oil:gas coefficient), open its explanationPotency: higher solubility, lower MAC (Meyer–Overton)

Agent-specific effects

AgentIts own effect
Halothane, rising dose, open its explanationCardiac output falls most
Cyclopropane, open its explanationFlammable; fluorinated agents do not burn
Halothane, open its explanationImmune‑mediated hepatitis, highest risk
Nitrous oxide alone, open its explanationRaises cerebral blood flow; cerebral CO2 response preserved
Sevoflurane and heart rate, open its explanationFlat below 1.5 MAC (Barash); Faust's 1 MAC is class‑wide
Desflurane with dried absorbent, open its explanationMost carbon monoxide; not sevoflurane or halothane
Nitrous oxide stopped, open its explanationDiffusion hypoxia: give 100% oxygen briefly

Report a problem with card 19: Volatile agents and gases

Drug, class and receptor

20 / 21

Name the class or receptor; the class predicts the effect.

Vaughan Williams classes (Lei 2018) and their official name endings

Class · name endingBlocks · ECG · drugs
Class Ia · -cain-, open its explanationSodium · wider QRS, longer QT · quinidine, procainamide, disopyramide
Class Ib · -cain-, open its explanationSodium, weakest · little effect on normal tissue · lidocaine, mexiletine
Class Ic · -cain-, open its explanationSodium, strongest · much wider QRS · flecainide, propafenone
Class II · -olol, open its explanationBeta receptors · slower rate, longer PR · esmolol
Class III · -ilide, open its explanationPotassium · longer QT · amiodarone, bretylium, sotalol, dofetilide
Class IV · no ending, open its explanationNodal calcium channels · longer PR · verapamil, diltiazem
Exception: sotalol, open its explanationEnds in -olol, yet class III: potassium block dominates
Outside the four classes, open its explanationAdenosine, digoxin, magnesium

Drug classes

DrugClass
Ethacrynic acid, open its explanationLoop diuretic without a sulfonamide group
Nalbuphine, open its explanationMixed opioid agonist–antagonist
Milrinone, open its explanationPhosphodiesterase III inhibitor; no adrenoceptor action
Hydralazine, open its explanationDirect systemic arterial vasodilator
Sarin, open its explanationIrreversible acetylcholinesterase inhibitor
Vecuronium, rocuronium, pancuronium, open its explanationAminosteroid non‑depolarising blocker; sugammadex reverses
Atracurium, cisatracurium, mivacurium, tubocurarine, open its explanationBenzylisoquinolinium non‑depolarising blocker; more histamine

Receptor and channel targets

DrugTarget
Phenylephrine, open its explanationEssentially pure alpha‑1 agonist
Isoprenaline (isoproterenol), open its explanationMost potent beta‑2 agonist
Noradrenaline, open its explanationBinds alpha‑2 more strongly than adrenaline
Ethanol and lidocaine, open its explanationDesensitise nicotinic receptors; fentanyl does not
Gabapentin or pregabalin, open its explanationAlpha‑2‑delta subunit of voltage‑gated calcium channels; not gamma‑aminobutyric acid (GABA)
Ketamine, open its explanationN‑methyl‑D‑aspartate (NMDA) block: dissociative anaesthesia

Effects to expect

DrugEffect to expect
Ketamine alone, open its explanationBronchodilator, tachycardia, more saliva; breathing kept unless sedatives added
Angiotensin‑converting enzyme (ACE) inhibitor, open its explanationNatriuresis: an indirect diuretic
ACE inhibitor, open its explanationLowers afterload; raises cardiac output, renal flow
Fenoldopam, open its explanationDopamine D1 vasodilator; alternative to nitroprusside
Sodium nitroprusside, open its explanationImpairs platelet aggregation; raises intracranial pressure; cyanide risk
Hydralazine, open its explanationReflex tachycardia beyond baroreflex; avoid in ischaemic heart disease
Anticholinesterase at the motor nerve ending, open its explanationLonger terminal action potential; repetitive firing
Sarin, open its explanationCholinergic crisis at muscarinic and nicotinic receptors

Autonomic transmitters

Autonomic siteTransmitter or receptor
Postganglionic sympathetic ending, open its explanationReleases noradrenaline; presynaptic alpha‑2 autoreceptors limit release
Cardiac vagal slowing, open its explanationMuscarinic M2 receptor

Report a problem with card 20: Drug, class and receptor

TrapsCheck these before you finish1 card · about 1 min

  1. 21Traps

Traps

21 / 21

The tempting call is the familiar one; the books often name another.

TemptingRight call
Glaucoma: succinylcholine absolutely contraindicated, open its explanationSuccinylcholine allowed; open globe only with deep anaesthesia, full block
Scopolamine for strongest drying of secretions, open its explanationGlycopyrrolate: most potent antisialagogue, less tachycardia than atropine
Preterm fentanyl apnoea: immature barrier keeps drug out, open its explanationExcess free fentanyl reaching brain, not kept out
Promethazine for nausea in Parkinson's disease, open its explanationOndansetron; promethazine is contraindicated
Vecuronium for re‑paralysis after sugammadex, open its explanationUrgent: succinylcholine; otherwise benzylisoquinolinium. Vecuronium waits 4 hours
Fentanyl for normal BIS despite anaesthesia, open its explanationNitrous oxide (barely moves BIS) or ketamine (raises it)
Green urine as a propofol infusion syndrome sign, open its explanationHarmless propofol effect; not a syndrome feature
Echothiopate as a prolonger of non‑depolarising block, open its explanationProlongs succinylcholine and mivacurium, the plasma‑cholinesterase substrates
Tramadol as mild opioid with MAO inhibitor, open its explanationAvoid tramadol, pethidine, methadone; choose morphine
Succinylcholine and rocuronium both on total weight, open its explanationSuccinylcholine total body weight; rocuronium lean weight
At two twitches, give neostigmine 50 mcg/kg together with atropine, open its explanationVentilate until four twitches, then neostigmine 40–50 mcg/kg
Plasma cholinesterase rises in pregnancy, open its explanationFalls 20–30%; succinylcholine slightly prolonged, clinically trivial

Report a problem with card 21: Traps

QuizCheck yourself21 practice scenarios · one to a screen

QuizCheck yourself21 practice scenariosAnswers checked against the books and guidelines.

Sheet 03 · Pharmacology21 / 21

That is Pharmacology, all 21 cards.

Your answers:

Back to the sheets

The 21 rules

One rule per card, in the sheet's order. Tap one to open its card.

Review the rules

Bookmarks

All cards

Your answers:

The coverThe end

Explanation